WHAT IS VIRPAS TABLETS? 

Virpas Tablets is mix of two hepatitis C infection (HCV) antiviral medications in a solitary shape. Each single tablet contains ledipasvir 90mg and sofosbuvir 400 mg. 

USES OF VIRPAS TABLETS: 

It is a mix of ledipasvir and sofosbuvir and is utilized to treat endless (durable) hepatitis C, a viral contamination of the liver. It might once in a while be utilized with another antiviral pharmaceutical (ribavirin). These medications work by decreasing the measure of hepatitis C infection in your body, which enables your resistant framework to battle the contamination and may enable your liver to recuperate. 

POSSIBLE SIDE EFFECTS: 

Tiredness, cerebral pain, sickness, loose bowels, or trouble resting may happen. In the event that any of these impacts hold on or compound, tell your specialist or drug specialist expeditiously. 

COMMON SIDE EFFECTS MAY INCLUDE: 

An intense unfavorably susceptible response to this medication is uncommon. In any case, get restorative help immediately on the off chance that you see any manifestations of a genuine hypersensitive response, including: rash, tingling/swelling (particularly of the face/tongue/throat), serious dazedness, inconvenience relaxing. 

DRUGS PRECAUTIONS: 

Take this drug in the dosage and span as exhorted by your specialist. Gulp down it as an entire. Try not to bite, squash or break it. Virpas 90 mg/400mg Tablet might be taken with or without sustenance, yet it is smarter to require it at a settled investment. 

Virpas 90 mg/400mg Tablet is a blend of two antiviral prescriptions: Ledipasvir and Sofosbuvir. They work by bringing down the measure of hepatitis C infection in the body and expelling the infection from the blood over some stretch of time. 

DRUGS INTERACTIONS: 

Virpas 90 mg/400mg Tablet is most likely safe to use amid lactation. Constrained human information proposes that the medication does not speak to a critical hazard to the infant. 

Virpas 90 mg/400mg Tablet ought to be utilized with alert in patients with serious kidney illness. Dosage modification of Virpas 90 mg/400mg Tablet might be required. If it’s not too much trouble counsel your specialist. 

Constrained data is accessible on utilization of Virpas 90 mg/400mg Tablet in these patients. No measurements alteration is prescribed in patients with mellow to direct kidney illness. 

Try not to drive except if you are feeling admirably. 

Virpas 90 mg/400mg Tablet, when taken together with different pharmaceuticals for the treatment of hepatitis c disease, may deliver unsteadiness, obscured vision and this may influence your capacity to drive.

Virso
Sofosbuvir Tablets Details:

ABOUT VIVITRA 150MG INJECTION

Vivitra 150 mg  (Trastuzumab) is a high biosimilar restorative result of reference biologic. It is an adapted monoclonal against HER2 (Human epidermal development factor receptor 2) counter acting agent. It includes 1328-amino acids; glycoprotein. 

Breast Cancer Drugs for Vivitra (Trastuzumab) is shown in which condition? 

Metastatic Breast Cancer (MBC): Vivitra  (Trastuzumab) is shown for the treatment of patients with HER2 over expressing metastatic bosom malignancy. Triumvirate (Trastuzumab) is additionally shown in blend with aromatase inhibitor for the treatment of patients with HER2 over expressing and hormone receptor-positive metastatic bosom disease. 

Early Breast Cancer (EBC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing early bosom malignancy following surgery, chemotherapy (neo adjuvant or adjuvant) and radiotherapy (if relevant). VivitraTM (Trastuzumab) is likewise demonstrated for adjuvant treatment of patients with HER2 overexpressing hub positive or hub negative bosom malignancy i) as a component of treatment regimen involving doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel ii) with docetaxel and carboplatin. 

Metastatic Gastric Cancer (MGC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal intersection adenocarcinoma in mix with capecitabine or 5-fluorouracil and cisplatin who have not gotten earlier hostile to malignancy treatment for their metastatic illness. 

Breast Cancer Drugs for Vivitra (Trastuzumab) work

The HER2 quality encodes the receptor tyrosine kinase HER2 and is regularly finished communicated in bosom malignancy and gastric cancer.2,3 Increased number of HER2 adds to tumor movement. 

Bosom diseases can have up to 25–50 duplicates of the HER2 quality and up to 40–100 crease increment in HER2 protein bringing about 2 million receptors communicated at the tumor cell surface. 

Expanded HER2 flagging assumes a part in expanded expansion and survival of the essential tumor and inaccessible sores endless supply of full change cause metastases. 

Around 1 out of 5 of gastric malignancies has excessively of a development advancing protein called HER2/neu (or only HER2) on the surface of the disease cells. Tumors with expanded levels of HER2 are called HER2positive-HER2 +ve.3 

Roughly 1 out of 5 patients with bosom disease has HER2-positive bosom cancer.

ABOUT VIVITRA INJECTION

Vivitra 440mg  (Trastuzumab) is a high biosimilar restorative result of reference biologic. It is an adapted monoclonal against HER2 (Human epidermal development factor receptor 2) counter acting agent. It includes 1328-amino acids; glycoprotein. 

Breast Cancer Drugs for Vivitra (Trastuzumab) is shown in which condition? 

Metastatic Breast Cancer (MBC): Vivitra  (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic bosom malignancy. VivitraTM (Trastuzumab) is additionally shown in blend with aromatase inhibitor for the treatment of patients with HER2 overexpressing and hormone receptor-positive metastatic bosom disease. 

Early Breast Cancer (EBC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing early bosom malignancy following surgery, chemotherapy (neo adjuvant or adjuvant) and radiotherapy (if relevant). VivitraTM (Trastuzumab) is likewise demonstrated for adjuvant treatment of patients with HER2 overexpressing hub positive or hub negative bosom malignancy i) as a component of treatment regimen involving doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel ii) with docetaxel and carboplatin. 

Metastatic Gastric Cancer (MGC): Vivitra (Trastuzumab) is shown for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal intersection adenocarcinoma in mix with capecitabine or 5-fluorouracil and cisplatin who have not gotten earlier hostile to malignancy treatment for their metastatic illness. 

Breast Cancer Drugs for Vivitra (Trastuzumab) work

The HER2 quality encodes the receptor tyrosine kinase HER2 and is regularly finished communicated in bosom malignancy and gastric cancer.2,3 Increased number of HER2 adds to tumor movement. 

Bosom diseases can have up to 25–50 duplicates of the HER2 quality and up to 40–100 crease increment in HER2 protein bringing about 2 million receptors communicated at the tumor cell surface. 

Expanded HER2 flagging assumes a part in expanded expansion and survival of the essential tumor and inaccessible sores endless supply of full change cause metastases. 

Around 1 out of 5 of gastric malignancies has excessively of a development advancing protein called HER2/neu (or only HER2) on the surface of the disease cells. Tumors with expanded levels of HER2 are called HER2positive-HER2 +ve.3 

Roughly 1 out of 5 patients with bosom disease has HER2-positive bosom cancer.

ABOUT VONADAY

Lamivudine belongs to a class of medication called nucleoside reverse transcriptase inhibitors. It decreases the amount of virus (HIV and hepatitis) in the blood. It also increases the number of infection fighting cells in the body (CD4 cells. Tenofovir is an antiviral drug belonging to class nucleoside reverse transcriptase inhibitors (NRTIs). Efavirenz belongs to a class of antiretroviral medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It inhibits the replication of HIV, thereby reducing the amount of the virus in the blood.

MEDICINE USES :

Lamivudine indicated as part of antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected. Tenofovir is used in combination with other antiviral drugs in the treatment of human immunodeficiency virus (HIV) infections. Efavirenz is used in combination with other medications for the treatment of human immunodeficiency virus (HIV) infection.

LAMIVUDINE/TENOFOVIR/EFAVIRENZ COMMON SIDE EFFECTS :

dizziness, drowsiness, tired feeling; nausea, diarrhea; headache, depressed mood, trouble concentrating; sleep problems (insomnia), strange dreams; rash; or changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

    unusual thoughts or behavior, anger, severe depression, thoughts of hurting yourself or others, hallucinations; a seizure (convulsions);
    kidney problems–increased thirst and urination, muscle pain or weakness; liver problems–nausea, upper stomach pain, itching, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
    severe skin reaction–fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
    signs of a new infection–fever, night sweats, swollen glands, mouth sores, cold sores, sores on your genital or anal area, diarrhea, stomach pain, weight loss;
    chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath; rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement;
    trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

 VONADAY LAMIVUDINE/TENOFOVIR/EFAVIRENZ TABLETS PRECAUTIONS :

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

    Avoid pregnancy
    Discontinue use if rapid increase in aminotransferase levels, progressive hepatomegaly, or metabolic or lactic acidosis of unknown origin
    Do not take tenofovir with other drugs that can potentially damage kidneys
    Do physical examination of fat redistribution
    Have diabetes and renal impairment
    Monitor blood levels of lipids and sugar in elderly

STORAGE REQUIREMENTS :

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Dispense only in original container; do not use if seal on bottle is broken or missing.

DRUG INTERACTIONS :

Vonaday Tablet may interact with the following drugs and products:

    Acyclovir
    Atazanavir
    Cidofovir
    Didanosine
    Ganciclovir
    Lopinavir

This document does not contain all possible interactions. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate is a combination antiviral medication that prevents human immunodeficiency virus (HIV) from reproducing in your body. It belongs to class of medication called antiretroviral medicines. It works by inhibiting the enzyme needed for DNA synthesis (nucleoside reverse transcriptase) thereby lowering the growth and decrease the amount of HIV in body.

MEDICINAL USES :

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). It is not a cure for HIV or AIDS. Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate is for use in adults and children who are at least 12 years old.

POSSIBLE SIDE EFFECTS :

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Early symptoms of lactic acidosis may get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms: muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, stomach pain, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired.

    unusual thoughts or behavior, anger, severe depression, thoughts of hurting yourself or others, hallucinations; a seizure (convulsions);
    kidney problems–increased thirst and urination, muscle pain or weakness; liver problems–nausea, upper stomach pain, itching, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
    severe skin reaction–fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
    signs of a new infection–fever, night sweats, swollen glands, mouth sores, cold sores, sores on your genital or anal area, diarrhea, stomach pain, weight loss;
    chest pain (especially when you breathe), dry cough, wheezing, feeling short of breath; rapid heart rate, feeling anxious or irritable, weakness or prickly feeling, problems with balance or eye movement;
    trouble speaking or swallowing, severe lower back pain, loss of bladder or bowel control; or swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence, loss of interest in sex.

Common side effects may include:

    dizziness, drowsiness, tired feeling; nausea, diarrhea; headache, depressed mood, trouble concentrating; sleep problems (insomnia), strange dreams;
    rash; or changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

STORAGE :

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Dispense only in original container; do not use if seal on bottle is broken or missing.